Old Crow Medicine Show Extends 2026 Union Made Tour

Why It Matters

The expansion taps high‑demand Northeast venues, boosting ticket revenue and reinforcing the band's national touring footprint as live‑music demand rebounds.

Key Takeaways

• Five new September shows added across NJ, NY, VT, WV
• Palmyra will open every Northeast date on the Union Made Tour
• Texino joins as special guest for the Shelburne, VT performance
• Presale starts tomorrow 10 a.m. ET; general sale Friday

Pulse Analysis

Old Crow Medicine Show, the Grammy‑winning string band known for hits like “Wagon Wheel,” continues its aggressive 2026 Union Made Tour with a fresh leg in the Northeast. After covering the Midwest, Southeast and Mountain West, the group is now playing five additional dates from September 15 to 20, featuring longtime collaborators Palmyra and, for the Vermont stop, the Nashville duo Texino. The added shows underscore the band’s strategy of maintaining momentum through a staggered, region‑focused schedule that keeps fans engaged throughout the year.

The Northeast circuit represents one of the most lucrative live‑music markets in the United States, with venues such as Hackensack Meridian Health Theatre and Metropolitan Theatre consistently selling out. By inserting these dates, Old Crow Medicine Show can capture higher ticket prices and ancillary revenue from merchandise, while leveraging Ticketmaster and AXS platforms to maximize reach. The presale code OCMS26 offers fans early access, a tactic that drives urgency and helps gauge demand before the general sale on Friday.

Industry analysts see the band’s tour extension as a micro‑example of a broader post‑pandemic trend: artists are adding secondary legs to capitalize on pent‑up demand and regional fan bases. For legacy acts like Old Crow Medicine Show, such moves not only boost immediate box‑office receipts but also reinforce brand relevance in competitive streaming eras. As touring revenue rebounds, the ability to flexibly expand itineraries will likely become a standard playbook for touring managers seeking sustainable growth.